HDAC9 and lung cancer: Sulforaphane also has an inhibitory effect on histone deacetylase (HDAC) activity [239], and its inhibitory effect on HDAC is addressed in breast, prostate, colon, and lung cancer cells [236,237,238,240] (Figure 8).